Mitochondrial oxidative stress and heart failure

52Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Recent experimental and clinical studies have suggested that oxidative stress is enhanced in heart failure. Chronic increases in oxygen radical production in the mitochondria can lead to a catastrophic cycle of mitochondrial DNA (mtDNA) damage as well as functional decline, further oxygen radical generation, and cellular injury. Reactive oxygen species induce myocyte hypertrophy, apoptosis, and interstitial fibrosis by activating matrix metalloproteinases. These cellular events play an important role in the development and progression of maladaptive cardiac remodeling and failure. Overexpression of mitchondrial transcription factor A (TFAM) could ameliorate the decline in mtDNA copy number and preserve it at a normal level in failing hearts. Consistent with alterations in mtDNA, the decrease in oxidative capacities was also prevented. Therefore, the activation of TFAM expression could ameliorate the pathophysiological process seen in myocardial failure. Inhibition of mitochondrial oxidative stress and DNA damage could be the most effective and novel treatment strategies for heart failure. © 2006 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Tsutsui, H. (2006, August 1). Mitochondrial oxidative stress and heart failure. Internal Medicine. https://doi.org/10.2169/internalmedicine.45.1765

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free